A small appetite or blood sugar effect, if it happens, should not be treated as a major weight loss strategy
Months 1+2+3+4: Enjoy 15% OFF
WHO World Health Organization , Use of GLP-1 analogues in the treatment of obesity, 2th December 2025 ANSM (National Agency for the Safety of Medicines and Health Products) , GLP-1 analogues: update on the monitoring of serious adverse effects and misuse Published on July 05, 2024 and updated on January 07, 2026 ANSM (National Agency for the Safety of Medicines and Health Products) , Monitoring of GLP-1 aglycones: ANSM confirms the favorable benefit/risk ratio when these drugs are used in accordance with recommendations
Headaches Semaglutide headaches result from dehydration, appetite changes, or shifting blood sugar levels
You can view the complete structural layout and Technical specifications on our product page
doi: 10.1038/modpathol.2014.113